XETRA · UCITS ETF
Invest in GN0M ETF from India
Indian and foreign residents can buy Global X Genomics & Biotechnology UCITS ETF (GN0M) units directly through Paasa.
By Paasa · Updated
GN0M at a glance
- Price
- €10.84+€0.04 (0.35%)
- Expense ratio
- —
- Day range
- €10.50 – €10.87
- Assets
- —
- Domicile
- Ireland
- Holdings
- —
- Launched
- —
- Dividends
- —
- 1 month
- -1.36%
- 6 months
- +57.56%
- YTD
- +55.52%
- 1 year
- +56.65%
- 5 years
- —
Price change, excluding dividends.
Top 10 holdings
- 1MODERNA INC11.4%
- 2TWIST BIOSCIENCE CORP5.7%
- 3GUARDANT HEALTH INC5.5%
- 410X GENOMICS INC-CLASS A5.2%
- 5NATERA INC5.2%
- 6ILLUMINA INC5.0%
- 7GENSCRIPT BIOTECH CORP3.9%
- 8VERTEX PHARMACEUTICALS INC3.6%
- 9QIAGEN N.V.3.6%
- 10BIO-TECHNE CORP3.5%
These 10 are 52.5% of the fund.
Similar funds
| Fund | Expense ratio | Assets |
|---|---|---|
| GNOMNASDAQGlobal X - Genomics & Biotechnology ETF | 0.5% | 112.9M |
| GNOMLSEGlobal X - Genomics & Biotechnology UCITS ETF | 0.5% | 149.0M |
Assets are shown in each fund's own reporting currency.
How to invest in GN0M from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search GN0M and buy
Find the fund by its ticker, GN0M, on XETRA, and place your order.
Why invest in GN0M from India
What GN0M holds
The Funds investment objective is to generate returns that closelyrncorrespond, before fees and expenses, generally to the price and yieldrnperformance of the Solactive Genomics v2 Index
Outside US estate tax
GN0M is domiciled in Ireland, not the US, so it is not a US-situs asset and US estate tax does not apply to it.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Why GN0M's UCITS structure matters for Indian investors
GN0M is domiciled in Ireland, not the US, so it is not a US-situs asset and US estate tax does not apply to it.
On the US shares the fund holds, the 15% US dividend withholding is paid inside the fund, and you cannot claim it as a Foreign Tax Credit in India.
Capital gains are taxed in India the same way as on a US-listed ETF.
Frequently asked questions
Can I buy GN0M from India?
Yes. Indian residents can buy Global X Genomics & Biotechnology UCITS ETF (GN0M) through Paasa. It is listed on XETRA and trades in EUR. Your money leaves India under the RBI's Liberalised Remittance Scheme, and the units are held in your own name at Interactive Brokers.
What does GN0M invest in?
Its largest holdings are MODERNA INC (11.4%), TWIST BIOSCIENCE CORP (5.7%) and GUARDANT HEALTH INC (5.5%). The fund is domiciled in Ireland.
Is GN0M a UCITS ETF, and why does that matter for Indian investors?
Yes. Global X Genomics & Biotechnology UCITS ETF is a UCITS fund domiciled in Ireland. Because it is domiciled outside the US, it is not a US-situs asset, so US estate tax does not apply to it. On the US shares the fund holds, the 15% US dividend withholding is paid inside the fund, and you cannot claim it as a Foreign Tax Credit in India.
What tax do I pay in India when I sell GN0M?
In India, gains on foreign ETF units held for more than 24 months are long-term and taxed at 12.5% without indexation, and gains on units held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.